A novel sympathetic neuronal GABAergic signalling system regulates NE release to prevent ventricular arrhythmias after acute myocardial infarction

Acta Physiologica
Yugen ShiSuhua Yan


Overactivation of the sympathetic nerve may lead to severe ventricular arrhythmias (VAs) after myocardial infarction (MI). Thus, targeting sympathetic nerve activity is an effective strategy to prevent VAs clinically. The superior cervical ganglion (SCG), the extracardiac sympathetic ganglion innervating cardiac muscles, has been found to have a GABAergic signalling system, the physiological significance of which is obscure. We aimed to explore the functional significance of SCG post MI and whether the GABAergic signal system is involved in the process. Adult male Sprague-Dawley rats were divided into seven different groups. Rats in the MI groups underwent ligation of the left anterior descending coronary artery. All animals were used for electrophysiological testing, renal sympathetic nerve activity (RSNA) testing, and ELISA. Primary SCG sympathetic neurons were used for the in vitro study. The GABAA receptor agonist muscimol significantly decreased the ATP-induced increase in intracellular Ca2+ (P < 0.05). GABA treatment in MI rats significantly attenuated the level of serum and cardiac norepinephrine (NE; P < 0.05). Sympathetic activity and inducible VAs were also lower in MI + GABA rats than in MI rats (P < 0.05). Knockdown...Continue Reading


Feb 1, 1992·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·J Kerrison, J E Freschi
Apr 1, 1990·British Journal of Pharmacology·T G Smart, A Constanti
Mar 1, 1968·Circulation Research·W C RandallM P Kaye
Feb 7, 1997·Science·E A Newman, K R Zahs
Sep 11, 2003·The Journal of Pharmacology and Experimental Therapeutics·Gloria QueirozJorge Gonçalves
Sep 3, 2005·The Journal of Clinical Investigation·Michael Rubart, Douglas P Zipes
Nov 30, 2006·The Journal of Pharmacy and Pharmacology·Sumiyo SasakiMujo Kim
Dec 26, 2006·Autonomic Neuroscience : Basic & Clinical·J E de C LacerdaE M Krieger
Apr 6, 2007·Biological & Pharmaceutical Bulletin·Sumiyo SasakiTakako Yokozawa
Jun 22, 2007·Clinical and Experimental Pharmacology & Physiology·Tsugumi MorikawaKazumasa Shinozuka
May 14, 2009·Basic Research in Cardiology·Gwenaelle WernliPeter G Smith
Aug 22, 2009·Cardiovascular Research·Tsung-Ming LeeNen-Chung Chang
Jul 6, 2010·Biochemical and Biophysical Research Communications·Zhenzhong ZhouJingxin Li
Jul 27, 2010·Advances in Pharmacology·De-Pei Li, Hui-Lin Pan
Feb 24, 2011·The Journal of Biological Chemistry·Amulya Nidhi ShrivastavaIsabella Sarto-Jackson
Jun 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Nepton SoltaniQinghua Wang
Jul 16, 2013·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Dominik LinzHans-Ruprecht Neuberger

❮ Previous
Next ❯


Aug 28, 2020·Acta Physiologica·Kathleen CantowErdmann Seeliger
Jan 29, 2021·Frontiers in Cell and Developmental Biology·Yu-Hang ZhangYu-Dong Cai

❮ Previous
Next ❯

Methods Mentioned


Software Mentioned

‐ Chart Pro

Related Concepts

Related Feeds

Cardiac Electrophysiology

Cardiac electrophysiology is the study of electrical activities of the heart and includes the assessment, diagnosis, and treatment of cardiac events. Find the latest research on cardiac electrophysiology here.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.